EICHOR
● Completed
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
Condition: Plaque Psoriasis · Scalp Psoriasis · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate the efficacy of guselkumab treatment versus placebo in skin of color participants with predominant moderate-to-severe body psoriasis or predominant moderate-to-severe scalp psoriasis by assessing improvements in the signs and symptoms of psoriasis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (94)
| Total Skin and Beauty Dermatology Center | Birmingham, Alabama, United States | — |
| Cahaba Research Inc | Birmingham, Alabama, United States | — |
| Stoll Dermatology | Beverly Hills, California, United States | — |
| California Dermatology & Clinical Research Institute | Encinitas, California, United States | — |
| First OC Dermatology | Fountain Valley, California, United States | — |
| Center for Dermatology Clinical Research | Fremont, California, United States | — |
| Community Regional Medical Center | Fresno, California, United States | — |
| Paul Wallace MD | Ladera Heights, California, United States | — |
| The Grimes Center for Medical and Aesthetic Dermatology | Los Angeles, California, United States | — |
| Care Access Research 1 | Newport Beach, California, United States | — |
| MedDerm Associates | San Diego, California, United States | — |
| Synergy Clinical Research | San Francisco, California, United States | — |
+ 82 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05272150